Clinical trials for Shingles

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Shingles. For all clinical trials, go to clinical trials search

This list shows clinical trials for Shingles

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Shingles
Title Recruitment status Location
A Phase 3, Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter Clinical Study of Eslicarbazepine Acetate in Post-Herpetic Neuralgia Not Recruiting United Kingdom
[S,S]-REBOXETINE ADD-ON TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER TRIAL OF [S,S]-REBOXETINE IN PATIENTS WITH POSTHERPETIC NEURALGIA (PHN) CONCOMITANTLY TREATED WITH PREGABALIN. - NA Not Recruiting United Kingdom
Safety and efficacy of lidocaine 5% medicated plaster in comparison with pregabalin in postherpetic neuralgia and diabetic polyneuropathic pain - n.a. Not Recruiting United Kingdom
A double-blind, placebo-controlled, enriched enrolment, randomised withdrawal study to evaluate the efficacy and safety of 2PX in patients with neuropathic pain due to post-herpetic neuralgia - 2PX in PHN Not Recruiting United Kingdom
Study to evaluate GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults aged >= 50 years. Not Recruiting United Kingdom
Study to evaluate GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults aged =70 years. Not Recruiting United Kingdom
A study in which multiple applications of Qutenza are investigated in patients with nerve pain Not Recruiting United Kingdom
A Phase 3, Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter Clinical Study of Eslicarbazepine Acetate in Post-Herpetic Neuralgia Not Recruiting United Kingdom
A Multicentre, Single-Arm, Open-Label Study Of The Repeated Administration Of QUTENZA For The Treatment Of Peripheral Neuropathic Pain Not Recruiting United Kingdom
A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the safety and efficacy of SAB378 (15 mg t.i.d.) administered orally for 4 weeks to patients with postherpetic neuralgia Not Recruiting United Kingdom

Page last reviewed: 22/06/2010

Next review due: 22/06/2012